Letermovir can be used for CMV prophylaxis after stem cell transplant but isn't currently approved for treatment. It can be started for prophylaxis in high risk patients once CMV viremia clears. #OTILT @KazanjianAlin @BWDionne @jeffpears0n https://t.co/1MP
134 followers
8 followers
Interestingly, its bioavailability decreases to 35% in allogeneic hematopoietic stem cell transplant recipients (vs. 94% in healthy patients), but is increased to 85% when given with cyclosporine. @BWDionne @jeffpears0n @thatpharmgirl #OTILT https://t.co/
58 followers
RT @HelouGuyTxID: What we know about Letermovir at this time https://t.co/D4A2wGBaky
36,288 followers
RT @HelouGuyTxID: What we know about Letermovir at this time https://t.co/D4A2wGBaky
539 followers
RT @HelouGuyTxID: What we know about Letermovir at this time https://t.co/D4A2wGBaky
10,436 followers
RT @HelouGuyTxID: What we know about Letermovir at this time https://t.co/D4A2wGBaky
171 followers
What we know about Letermovir at this time https://t.co/D4A2wGBaky